AdaptHealth (AHCO) Current Deferred Revenue (2018 - 2026)

AdaptHealth's Current Deferred Revenue history runs 9 years deep, the most recent figure standing at $59.7 million for Q1 2026.

• In Q1 2026, Current Deferred Revenue rose 28.59% year-over-year to $59.7 million; the TTM figure through Mar 2026 stood at $59.7 million (up 28.59% YoY), while the FY2025 annual figure was $59.8 million, up 71.25% from the prior year.
• Current Deferred Revenue was $59.7 million for Q1 2026 at AdaptHealth, roughly flat from $59.8 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $59.9 million in Q3 2025 to a low of $30.6 million in Q1 2022.
• Historically, Current Deferred Revenue has averaged $41.3 million across 5 years, with a median of $35.8 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Current Deferred Revenue declined 25.3% in 2024, then soared 71.25% in 2025.
• A 5-year view of Current Deferred Revenue shows it stood at $31.6 million in 2022, then increased by 21.9% to $38.6 million in 2023, then fell by 9.4% to $34.9 million in 2024, then jumped by 71.25% to $59.8 million in 2025, then declined by 0.19% to $59.7 million in 2026.
• The last three Current Deferred Revenue figures came in at $59.7 million (Q1 2026), $59.8 million (Q4 2025), and $59.9 million (Q3 2025), per Business Quant data.